HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Kopelman Selected Research

Body Weight (Weight, Body)

3/2007Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Kopelman Research Topics

Disease

4Obesity
03/2007 - 12/2000
4Weight Loss (Weight Reduction)
03/2007 - 12/2000
1Metrorrhagia (Spotting)
03/2007
1Flatulence
03/2007
1Body Weight (Weight, Body)
03/2007
1Starvation
01/2001
1Coronary Disease (Coronary Heart Disease)
12/2000

Drug/Important Bio-Agent (IBA)

2sibutramine (Meridia)FDA Link
04/2001 - 12/2000
1Lipase (Acid Lipase)FDA Link
03/2007
1cetilistatIBA
03/2007
1LipidsIBA
03/2007
1LeptinIBA
01/2001
1AminesIBA
12/2000
1HDL CholesterolIBA
12/2000
1LDL CholesterolIBA
12/2000
1Triglycerides (Triacylglycerol)IBA
12/2000
1VLDL CholesterolIBA
12/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
03/2007
1Caloric Restriction
12/2000
1Therapeutics
12/2000